BlackRock »

BioMarin Pharmaceutical shares owned by BlackRock

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in BioMarin Pharmaceutical

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 291.55B1.56B1.57B1.58B1.59B22.6M22.8M23M23.2M23.4M
Value ($)Share countHistorical BMRN position of BlackRock Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by BlackRock

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.5B 24M 65.73
2024-09-30 $1.6B 23M 70.29

More positions owned by BlackRock

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Mastercard Incorporated Cl A (MA)

View all positions for BlackRock

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
Capital Research Global Investors
Viking Global Investors
State Street Corporation
Ameriprise Financial
Norges Bank Investment Management
Elliott Investment Management
Geode Capital Management
Bank of New York Mellon
Northern Trust
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co

View all funds holding BioMarin Pharmaceutical